Nct03710603 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nct03710603. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nct03710603 Today - Breaking & Trending Today

D-VRd Improves PFS in Newly Diagnosed, Transplant-Eligible Multiple Myeloma

Induction therapy with subcutaneous daratumumab followed by autologous stem cell transplant, daratumumab, bortezomib, lenalidomide, and dexamethasone consolidation and daratumumab/lenalidomide maintenance prolonged progression-free survival in patients with newly diagnosed, transplant-eligible multiple myeloma. ....

Subcutaneous Daratumumab , Autologous Stem Cell Transplant , Nd Dexamethasone Consolidation , Daratumumab Lenalidomide Maintenance , Patients With Newly Diagnosed , Transplant Eligible Multiple Myeloma , Perseus Trial , Pieter Sonneveld , Erasmus Mc Cancer Institute ,